Skip to main content

License single eBooks

Your results

Search and Filter

Showing 1 - 1 of 1
0 eBooks €0

  • Volume 2
    Christian Rommel; Bart Vanhaesebroeck; Peter K. Vogt
    978-3-642-14816-3
    2011
    Edition 1
    • From humble beginnings over 25 years ago as a lipid kinase activity associated with certain oncoproteins, PI3K (phosphoinositide 3-kinase) has been catapulted to the forefront of drug development in cancer, immunity and thrombosis, with the first clinical trials of PI3K pathway inhibitors now in progress.
    €400 €360
    10% OFF

Is this helpful?

Survey

Survey to collect feedback on the helpfulness of this page.

Survey

Survey to collect feedback on the helpfulness of this page.